Abstract
The increase in cases of fungal infections, particularly those caused by multidrug-resistant fungi, necessitates the development of new antifungal agents. Antimicrobial peptides (AMPs) have shown great promise in this context due to their ability to combat microorganisms resistant to traditional antibiotics. Polybia-MPII (MP2) and Polybia-MPI (MP1), peptides isolated from the venom of soc…